Nordette 150 ug/30 ug Sugar-coated tablets
PDF Leaflet Revision Date: 03 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Contraception and treatment of dysmenorrhea and dysfunctional uterine bleeding.
Dosage (summary)
One yellow tablet daily for 21 days, followed by one red tablet for 7 days.
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may affect milk production.
Key Drug Interactions
- Ritonavir
- Anticonvulsants
- Antibiotics
Contraindications
- Hypersensitivity to components
- History of thromboembolic disorders
- Uncontrolled hypertension
Common side effects
- Nausea
- Headache
- Breast tenderness
Counselling Points
- Take at the same time daily
- Use additional contraception if tablets are missed
- Monitor for signs of thromboembolism
Serious warnings
- Increased risk of thromboembolism
- Cigarette smoking increases cardiovascular risks
Important Disclaimer
The Nordette 150 ug/30 ug Sugar-coated tablets professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
